Thanks To The Supreme Court, Angelina Jolie's Breast Cancer Test Might Become More Affordable
Companies were patenting certain gene mutations. They lost in the Supreme Court Thursday. Here's everything you need to know.
You might know who Angelina Jolie is.
Myriad Genetics was sued and the case went to the Supreme Court, which ruled unanimously that isolated human genes can not be patented.
The ruling means other companies will legally be able to offer tests to find the breast cancer genes.
All was not lost for Myriad Genetics -- the justices ruled that artificial genes can be patented.
Regardless, it looks like soon more people will be able to afford a test to determine if they're at increased risk of breast cancer, just like Angelina did.